Faulkenberry v. Secretary of Health and Human Services

CourtUnited States Court of Federal Claims
DecidedJanuary 29, 2026
Docket19-0238V
StatusPublished

This text of Faulkenberry v. Secretary of Health and Human Services (Faulkenberry v. Secretary of Health and Human Services) is published on Counsel Stack Legal Research, covering United States Court of Federal Claims primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Faulkenberry v. Secretary of Health and Human Services, (uscfc 2026).

Opinion

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS

********************** AMY FAULKENBERRY, on behalf * of her minor son, WCF, * * No. 19-238V Petitioner, * Special Master Christian J. Moran * v. * * Filed: January 5, 2026 SECRETARY OF HEALTH * AND HUMAN SERVICES, * * Respondent. * **********************

M. Clay Ragsdale, IV, Ragsdale LLC, Birmingham, AL, for petitioner; Madelyn Weeks, United States Dep’t of Justice, Washington, DC, for respondent.

PUBLISHED DECISION AWARDING ATTORNEYS’ FEES AND COSTS1

Pending before the Court is petitioner Amy Faulkenberry’s motion for final attorneys’ fees and costs. She is awarded a total of $153,209.17.

1 Because this published decision contains a reasoned explanation for the action in this case, the undersigned is required to post it on the United States Court of Federal Claims' website in accordance with the E-Government Act of 2002. 44 U.S.C. § 3501 note (2018) (Federal Management and Promotion of Electronic Government Services). This posting means the decision will be available to anyone with access to the internet. In accordance with Vaccine Rule 18(b), the parties have 14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, the undersigned agrees that the identified material fits within this definition, the undersigned will redact such material from public access. I. Background2

WCF was born in July 2014. Exhibit 11. WCF visited the office of his pediatrician, Dr. Walker, for his 18-month check up on February 17, 2016. Exhibit 4 at 168. During this appointment, WCF received the second dose of the hepatitis A vaccine and flu vaccine. Id.; see also Exhibit 1 at 1.

Four days later, on February 21, 2016, WCF vomited in a Target store. An ambulance arrived and he was taken to a local emergency room. Exhibit 12 at 5-7. In the emergency room, doctors ran various tests and discharged him. Exhibit 9 at 74-88.

The following day, Dr. Walker saw WCF. Dr. Walker diagnosed him with an upper respiratory infection and vomiting. Exhibit 4 at 167.

The next item in the medical records occurred on March 6, 2016. WCF had convulsions. An ambulance again brought him to the hospital. Exhibit 12 at 10. This event marks the latest date that WCF might have first manifested symptoms of his anti-NMDAR encephalitis.

Over the next few weeks, WCF saw pediatricians and different neurologists. He was hospitalized for three days. Exhibit 10 at 5-7. Eventually, he tested positive for NMDA antibodies. Id. at 286.

Both experts agree that WCF’s diagnosis is anti-NMDAR encephalitis. Exhibit 22 (Dr. Marcus’s report) at 2-4; Exhibit A (Dr. Lancaster’s report) at 4.

II. Procedural History A. Before the Petition was Filed

According to the attorneys’ timesheets, Ms. Faulkenberry first communicated with Clay Ragsdale’s law firm in February 2018. As discussed below, Mr. Ragsdale and another attorney, Allison Espy, represented Ms.

2 Events in WCF’s life are presented summarily to provide some context for the actions taken in the litigation. For more detailed accounts of the medical records, see Pet’r’s Br., filed June 6, 2022, at 2-4 and Resp’t’s Revised Br., filed Feb. 2, 2023, at 2-12.

2 Faulkenberry. (Ms. Epsy was formerly known as Allison Riley.) These attorneys were assisted by various support staff, primarily a paralegal, Amy Johnson.

For about one year, members of the law firm developed evidence. A primary task was gathering medical records.

B. Petition to Expert Report Stage

On behalf of Ms. Faulkenberry, Mr. Ragsdale submitted the petition on February 12, 2019. Ms. Faulkenberry alleged the flu vaccine and the hepatitis A vaccine caused WCF to develop “acute encephalopathy post immunization and encephalitis/encephalomyelitis following immunization procedure,” as well as “severe developmental delay and regression.” Pet., filed Feb. 12, 2019, at 2. She periodically submitted medical records and affidavits. Shortly after the case was filed, an initial set of orders was issued. One order advised the attorneys about creating invoices to support an application for attorneys’ fees and costs. Order, issued Feb. 14, 2019. This order advised against certain practices such as: “Multiple attorneys working on a case,” “Block billing . . . A rule of thumb is that tasks that require more than one hour should be further refined,” and “Vague entries.” Mr. Ragsdale and Ms. Espy both charged for reading this order.

The Secretary opposed the claim for compensation. Resp’t’s Rep., filed July 31, 2019. The Secretary maintained that although an appropriate diagnosis was unclear, one possibility was anti-NMDAR encephalitis. Id. at 11. (As mentioned above, diagnosis is no longer an issue because after the Secretary filed his report, both experts agreed with the diagnosis of anti-NMDAR encephalitis.) The Secretary also contended that WCF may have manifested symptoms of anti- NMDAR encephalitis before the vaccination, in particular, that he was fussy and having trouble sleeping by November 2, 2015. Id. at 12. The Secretary also noted that Ms. Faulkenberry had not presented a report from a treating doctor or from a retained expert that causally connected the vaccinations to WCF’s condition. Id. at 12.

To facilitate the presentation of reports from experts, a set of instructions were proposed. When the parties did not object, the instructions became final. Order, issued Jan. 27, 2020.

3 C. Expert Report Stage

The parties submitted a series of reports from experts. Ms. Faulkenberry retained Dr. Lydia Marcus. Dr. Marcus is a board-certified pediatric neurologist. Exhibit 23 (curriculum vitae). Since 2019, she has been an assistant professor of pediatrics at the University of Alabama-Birmingham. At the time of her first report, she had written three articles published in peer-reviewed journals. Id. at 4. Another article reporting on a series of patients with anti-NMDAR encephalitis was pending review. Exhibit 22 at 1. In her first report, Dr. Marcus stated that she has treated approximately nine cases of anti-NMDAR encephalitis. Id.

Dr. Marcus’s first report is approximately five pages with an additional one and a half pages for references. Exhibit 22. Her report generally complies with the Expert Instructions. Dr. Marcus has charged 6.25 for her work on the first report. 3 As discussed below, Attorney Ragsdale, Attorney Espy, and Ms. Johnson also contributed to the preparation of Dr. Marcus’s report. These legal professionals have charged more than 25 hours for their work.

The Secretary’s expert is Dr. Lancaster. Dr. Lancaster is board certified in neurology. Exhibit B (curriculum vitae). He has “expertise in antibody-mediated neurologic disorders.” Id. at 1. Dr. Lancaster “completed several years of research fellowship at the University of Pennsylvania under the mentorship of Josep Dalmau, MD, PhD, who discovered anti-NMDAR encephalitis.” Exhibit A (report) at 1. Dr. Lancaster has written more than 30 peer-reviewed articles, some of which concern anti-NMDAR encephalitis. Exhibit B at 5-7. At time of his first report, Dr. Lancaster had treated approximately 50 patients with anti-NMDAR encephalitis. Exhibit A at 1-2. The 50 patients appear to be all adults, not children. Dr. Lancaster disagreed with some of the opinions Dr. Marcus had offered.

Ms. Faulkenberry obtained a supplemental report from Dr. Marcus. Exhibit 54. Dr. Marcus has charged four hours for preparing her report. 4 This report, which is dated June 10, 2021, is five pages with Dr. Marcus’s signature on the

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Hensley v. Eckerhart
461 U.S. 424 (Supreme Court, 1983)
Blum v. Stenson
465 U.S. 886 (Supreme Court, 1984)
Missouri v. Jenkins Ex Rel. Agyei
491 U.S. 274 (Supreme Court, 1989)
Greenlaw v. United States
554 U.S. 237 (Supreme Court, 2008)
Avera v. Secretary of Health and Human Services
515 F.3d 1343 (Federal Circuit, 2008)
Brenda Bennett v. Department of the Navy
699 F.2d 1140 (Federal Circuit, 1983)
Brass v. United States
127 Fed. Cl. 505 (Federal Claims, 2016)
Raymo v. Secretary of Health and Human Services
129 Fed. Cl. 691 (Federal Claims, 2016)
Guy v. Secretary of Health & Human Services
38 Fed. Cl. 403 (Federal Claims, 1997)

Cite This Page — Counsel Stack

Bluebook (online)
Faulkenberry v. Secretary of Health and Human Services, Counsel Stack Legal Research, https://law.counselstack.com/opinion/faulkenberry-v-secretary-of-health-and-human-services-uscfc-2026.